What is light chain deposition disease (LCDD) and how can it affect people with multiple myeloma and amyloid light-chain (AL) amyloidosis?
Find out the answer from Canadian myeloma expert:
Victor H Jimenez Zepeda, MD
Associate Professor of Medicine, University of Calgary
Co-director Amyloidosis Program of Calgary
Clinician Scientist for the Tom Baker Cancer Center